Ionis Pharmaceuticals in (ions 1.75 06/15/28)
13F holders, Q4 2024 (December 31)6holders +3
4new positions
1sold out
$1.18avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Ionis Pharmaceuticals in (ions 1.75 06/15/28) in their 13F filings, up 3 from Q3 2024. 4 opened new positions and 1 sold out. The largest holders were Sonora Investment Management Group, LLC ($5.4M), New York State Common Retirement Fund ($5.3M) and Nomura Holdings Inc. ($2.7M).
- Company
- Ionis Pharmaceuticals in (ions 1.75 06/15/28)
- CUSIP
- 462222AF7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $13.5M |
| Exits | 1 | $262K |
All 13F filers, Q3 2024 → Q4 2024: 10,976,282 shares bought and 250,000 shares sold, net +10,726,282 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Sonora Investment Management Group, LLC | 0.42% | New | 5,499,000 | $5.4M |
| New York State Common Retirement Fund | 0.01% | New | 5,362,000 | $5.3M |
| Nomura Holdings Inc. | 0.01% | New | 78,282 | $2.7M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,500,000 | $2.5M |
| Sei Investments Co. | 0.00% | No change | 262,000 | $258K |
| Choreo, LLC | 0.00% | New | 37,000 | $36K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 1.75 06/15/28)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 1.75 06/15/28) the manager owns.